vs

Side-by-side financial comparison of ICON PLC (ICLR) and Labcorp (LH). Click either name above to swap in a different company.

Labcorp is the larger business by last-quarter revenue ($3.5B vs $2.0B, roughly 1.7× ICON PLC). Labcorp runs the higher net margin — 4.7% vs 0.1%, a 4.6% gap on every dollar of revenue. On growth, Labcorp posted the faster year-over-year revenue change (5.7% vs 0.6%). Labcorp produced more free cash flow last quarter ($490.3M vs $333.9M). Over the past eight quarters, Labcorp's revenue compounded faster (4.5% CAGR vs 0.6%).

ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.

Labcorp is a leading global life sciences and diagnostic testing firm that offers comprehensive clinical laboratory services, drug development support, and medical testing solutions for healthcare providers, pharmaceutical companies, and individual patients. It uses advanced scientific expertise and innovative technologies to deliver accurate, actionable health insights that support clinical decisions, accelerate new treatment development, and improve patient health outcomes globally.

ICLR vs LH — Head-to-Head

Bigger by revenue
LH
LH
1.7× larger
LH
$3.5B
$2.0B
ICLR
Growing faster (revenue YoY)
LH
LH
+5.1% gap
LH
5.7%
0.6%
ICLR
Higher net margin
LH
LH
4.6% more per $
LH
4.7%
0.1%
ICLR
More free cash flow
LH
LH
$156.4M more FCF
LH
$490.3M
$333.9M
ICLR
Faster 2-yr revenue CAGR
LH
LH
Annualised
LH
4.5%
0.6%
ICLR

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
ICLR
ICLR
LH
LH
Revenue
$2.0B
$3.5B
Net Profit
$2.4M
$164.7M
Gross Margin
28.2%
Operating Margin
4.2%
7.6%
Net Margin
0.1%
4.7%
Revenue YoY
0.6%
5.7%
Net Profit YoY
-98.8%
14.9%
EPS (diluted)
$0.03
$1.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICLR
ICLR
LH
LH
Q1 26
$3.5B
Q4 25
$3.5B
Q3 25
$2.0B
$3.6B
Q2 25
$2.0B
$3.5B
Q1 25
$2.0B
$3.3B
Q4 24
$3.3B
Q3 24
$2.0B
$3.3B
Q2 24
$2.1B
$3.2B
Net Profit
ICLR
ICLR
LH
LH
Q1 26
$164.7M
Q4 25
$164.7M
Q3 25
$2.4M
$261.1M
Q2 25
$183.0M
$237.9M
Q1 25
$154.2M
$212.8M
Q4 24
$143.4M
Q3 24
$197.1M
$169.3M
Q2 24
$146.9M
$205.3M
Gross Margin
ICLR
ICLR
LH
LH
Q1 26
28.2%
Q4 25
28.2%
Q3 25
28.8%
Q2 25
29.7%
Q1 25
28.3%
Q4 24
26.9%
Q3 24
27.6%
Q2 24
28.8%
Operating Margin
ICLR
ICLR
LH
LH
Q1 26
7.6%
Q4 25
7.6%
Q3 25
4.2%
11.1%
Q2 25
10.4%
11.2%
Q1 25
11.0%
9.7%
Q4 24
6.5%
Q3 24
14.1%
7.7%
Q2 24
10.8%
9.2%
Net Margin
ICLR
ICLR
LH
LH
Q1 26
4.7%
Q4 25
4.7%
Q3 25
0.1%
7.3%
Q2 25
9.1%
6.7%
Q1 25
7.7%
6.4%
Q4 24
4.3%
Q3 24
9.7%
5.2%
Q2 24
6.9%
6.4%
EPS (diluted)
ICLR
ICLR
LH
LH
Q1 26
$1.98
Q4 25
$1.98
Q3 25
$0.03
$3.12
Q2 25
$2.30
$2.84
Q1 25
$1.90
$2.52
Q4 24
$1.72
Q3 24
$2.36
$2.00
Q2 24
$1.76
$2.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICLR
ICLR
LH
LH
Cash + ST InvestmentsLiquidity on hand
$468.9M
$532.3M
Total DebtLower is stronger
$5.1B
Stockholders' EquityBook value
$9.3B
$8.6B
Total Assets
$16.5B
$18.4B
Debt / EquityLower = less leverage
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICLR
ICLR
LH
LH
Q1 26
$532.3M
Q4 25
$532.3M
Q3 25
$468.9M
$598.1M
Q2 25
$390.4M
$647.3M
Q1 25
$526.7M
$369.4M
Q4 24
$1.5B
Q3 24
$695.5M
$1.5B
Q2 24
$506.6M
$265.1M
Total Debt
ICLR
ICLR
LH
LH
Q1 26
$5.1B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
ICLR
ICLR
LH
LH
Q1 26
$8.6B
Q4 25
$8.6B
Q3 25
$9.3B
$8.7B
Q2 25
$9.6B
$8.5B
Q1 25
$9.5B
$8.3B
Q4 24
$8.1B
Q3 24
$9.8B
$8.2B
Q2 24
$9.6B
$8.0B
Total Assets
ICLR
ICLR
LH
LH
Q1 26
$18.4B
Q4 25
$18.4B
Q3 25
$16.5B
$18.3B
Q2 25
$16.6B
$18.1B
Q1 25
$16.7B
$17.6B
Q4 24
$18.4B
Q3 24
$17.2B
$18.6B
Q2 24
$17.0B
$16.7B
Debt / Equity
ICLR
ICLR
LH
LH
Q1 26
0.59×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICLR
ICLR
LH
LH
Operating Cash FlowLast quarter
$387.6M
$614.2M
Free Cash FlowOCF − Capex
$333.9M
$490.3M
FCF MarginFCF / Revenue
16.3%
13.9%
Capex IntensityCapex / Revenue
2.6%
3.5%
Cash ConversionOCF / Net Profit
164.59×
3.73×
TTM Free Cash FlowTrailing 4 quarters
$1.0B
$1.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICLR
ICLR
LH
LH
Q1 26
$614.2M
Q4 25
$614.2M
Q3 25
$387.6M
$387.2M
Q2 25
$146.2M
$620.6M
Q1 25
$268.2M
$18.5M
Q4 24
$777.2M
Q3 24
$402.7M
$277.3M
Q2 24
$218.6M
$561.1M
Free Cash Flow
ICLR
ICLR
LH
LH
Q1 26
$490.3M
Q4 25
$490.3M
Q3 25
$333.9M
$280.5M
Q2 25
$113.9M
$542.7M
Q1 25
$239.3M
$-107.5M
Q4 24
$665.1M
Q3 24
$359.3M
$161.5M
Q2 24
$182.3M
$432.9M
FCF Margin
ICLR
ICLR
LH
LH
Q1 26
13.9%
Q4 25
13.9%
Q3 25
16.3%
7.9%
Q2 25
5.6%
15.4%
Q1 25
12.0%
-3.2%
Q4 24
20.0%
Q3 24
17.7%
4.9%
Q2 24
8.6%
13.4%
Capex Intensity
ICLR
ICLR
LH
LH
Q1 26
3.5%
Q4 25
3.5%
Q3 25
2.6%
3.0%
Q2 25
1.6%
2.2%
Q1 25
1.4%
3.8%
Q4 24
3.4%
Q3 24
2.1%
3.5%
Q2 24
1.7%
4.0%
Cash Conversion
ICLR
ICLR
LH
LH
Q1 26
3.73×
Q4 25
3.73×
Q3 25
164.59×
1.48×
Q2 25
0.80×
2.61×
Q1 25
1.74×
0.09×
Q4 24
5.42×
Q3 24
2.04×
1.64×
Q2 24
1.49×
2.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ICLR
ICLR

Other Customers$681.3M33%
Clients1125$549.4M27%
Clients15$503.3M25%
Clients610$308.8M15%

LH
LH

Revenues$2.7B78%
Other$787.3M22%

Related Comparisons